Discover 413 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Rochester has a wide variety of active clinical trials, focusing on conditions such as kidney disease, cancer, and cardiovascular disorders. Participants in these studies have the opportunity to explore emerging treatments in the city’s leading research institutions, both as healthy volunteers in paid trials and as individuals looking for studies targeting specific health conditions.
Filter
2
Filter results
Results: 413
Active & Responsive
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
for
Heart Failure
Location: 20 recruiting locations
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40 - 70+
Code: NCT06122779
Phase2, Recruiting
Active & Responsive
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
for
Urinary Tract Infections
Location: 6 recruiting locations
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 64
Code: NCT06702449
Phase1, Phase2, Recruiting
Active & Responsive
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Active & Responsive
Leverage Noninvasive Transcutaneous Vagus Nerve Stimulation to Reduce Suicidal Behaviors in Vulnerable Adolescents
for
Self Harm, Suicidal Ideation
Location: 2 recruiting locations
Sponsor: University of Notre Dame
Sex: All
Age: 13 - 17
Code: NCT05602779
Recruiting
Active & Responsive
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 44 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
for
Solid Tumor
Location: 7 recruiting locations
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT06364696
Phase1, Recruiting
Active & Responsive
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia